Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE004131 |
YEM_ID: | YEM-712 |
ID: | TCMBANKHE004131/YEM-712 |
植物拉丁名: |
|
功能与主治: | To clear heat and resolve toxin, dissipate stasis and disperse swelling./Swelling toxin of sore and welling abscess, insect bites, fish bone stuck in throat. |
药用植物名: | 水仙根|水仙 |
药名: | 水仙 |
来源: | 云南民族药物志：第四卷 |
药用部位: | bulb |
使用民族: | 阿昌族/傣族/德昂族/景颇族/傈僳族 |
TCM_ID_id: | 4837 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000038 | prim-o-glucosylcimifugin | NP-002658; ACon1_000472; BRD-A58428623-001-01-6; MCULE-1156118860; MEGxp0_000922; MolPort-001-741-075; NCGC00169046-01 | C22H28O11 | 468.4 g/mol | CC(C)(C1CC2=C(O1)C=C3C(=C2OC)C(=O)C=C(O3)COC4C(C(C(C(O4)CO)O)O)O)O |
| TCMBANKIN000168 | (+)-galbacin | C20H20O5 | 340.4 g/mol | CC1C(C(OC1C2=CC3=C(C=C2)OCO3)C4=CC5=C(C=C4)OCO5)C | |
| TCMBANKIN008568 | tadehaginoside | C21H22O10 | C1=CC(=CC=C1C=CC(=O)OCC2C(C(C(C(O2)OC3=CC(=CC(=C3)O)O)O)O)O)O | ||
| TCMBANKIN009560 | lycoramine | C17H23NO3 | 289.37 | CN1CCC23CCC(CC2OC4=C(C=CC(=C34)C1)OC)O.Br | |
| TCMBANKIN010568 | lycoxanthin | C40H56O | 552.9 g/mol | CC(=CCCC(=CC=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=CC=C(C)CCC=C(C)CO)C)C)C)C | |
| TCMBANKIN013638 | lycorenine | C18H23NO4 | 317.4 g/mol | CN1CCC2=CCC3C(C21)C4=CC(=C(C=C4C(O3)O)OC)OC | |
| TCMBANKIN017367 | galanthamine | Jilkon hydrobromide; SC-17309; 1,2,3,4,6,7,7a,11c- Octahydro-9- methoxy-2-methyl-benzofuro (4,3,2-efg)(2) benzazocin-6-ol hydrobromide; 1,2,3,4,6,7,7a,11c-Octahydro-9-methoxy-2-methyl-benzofuro (4,3,2-efg)(2) benzazocin-6-ol hydrobromide; SR-01000315928-1; Q-201145; Lycoremine hydrobromide; MolPort-035-394-945; SR-01000315928 | C17H21NO3 | 287.35 g/mol | CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O |
| TCMBANKIN017816 | tazettine | C18H21NO5 | 331.4 g/mol | CN1CC2(C3(C1CC(C=C3)OC)C4=CC5=C(C=C4CO2)OCO5)O | |
| TCMBANKIN023727 | pseudolycorine | C7H6O3 | 138.12 | COC1=C(C=C2C3C(C(C=C4C3N(CC4)CC2=C1)O)O)O | |
| TCMBANKIN026380 | pseudomorphine | C34H36N2O6 | 568.7 g/mol | CN1CCC23C4C1CC5=CC(=C(C(=C52)OC3C(C=C4)O)O)C6=C(C7=C8C(=C6)CC9C1C8(CCN9C)C(O7)C(C=C1)O)O | |
| TCMBANKIN031680 | papyramine | C18H23NO4 | 317.4 g/mol | COC1CC2C3(CCN2C(C4=CC(=C(C=C43)OC)OC)O)C=C1 | |
| TCMBANKIN033851 | pretazettine | C18H21NO5 | 331.4 g/mol | CN1CC2C3(C1CC(C=C3)OC)C4=CC5=C(C=C4C(O2)O)OCO5 | |
| TCMBANKIN043587 | para-aspidin | C25H32O8 | 460.5 g/mol | CCCC(=O)C1=C(C(=C(C(=C1O)C)OC)CC2=C(C(C(=O)C(=C2O)C(=O)CCC)(C)C)O)O | |
| TCMBANKIN058634 | lycorine | AC-20268; CHEMBL583716; 2-epi-Lycorine; ZINC21992900; AKOS015965245; Licorine; NCI60_003767; UNII-I9Q105R5BU; ST24047513; Amarylline; HMS3402B04; QTL1_000052; AN-24834; HMS1989B04; 3,3a-Didehydrolycoran-1alpha,2beta-diol; NSC-683873; AN-50515; AJ-46629; AX8136904; KBio3_000043; 3,12-[methylenebis(oxy)]-galanthan-1.alpha.,2.beta.-diol; MolPort-000-882-129; Galanthidine; Bio2_000022; KBioSS_000022; Lycorine hydrochloride; DTXSID60197208; NCGC00163413-02; EINECS 207-503-6; KBio2_005158; ZINC3881372; KBio2_000022; AC1L2HYJ; 2,4,5,7,12b,12c-Hexahydro-1H-[1,3]dioxolo[4,5-j]pyrrolo[3,2,1-de]phenanthridine-1,2-diol, (1S,2S,12bS, 12cS)-; CHEBI:6601; SC-19266; CCG-208232; GNF-PF-4974; KBio3_000044; C08532; LS-88398; AC1Q6ZRB; Lycoran-1-alpha,2-beta-diol, 3,3-alpha-didehydro-; MFCD00243111; Lycoran-1alpha,2beta-diol, 3,3a-didehydro- (8CI); SCHEMBL626071; NSC683873; Bio2_000502; (-)-Lycorine; CHEMBL400092; IDI1_033772; KBioGR_000022; KBio2_002590; BDBM50221066; HMS1361B04; NSC-401360; Likorin; MFCD00221746; NSC 401360; NCGC00163413-01; I9Q105R5BU; BSPBio_001302; 9,10-(methylenedioxy)-3,12-didehydrogalanthan-1alpha,2beta-diol; lycorine; MCULE-4471227410; BRD-K64909280-001-02-7; Galanthan-1, 3,4-didehydro-11,12-[methylenebis(oxy)]-, (1.alpha.,2.beta.)-; Lycoran-1alpha,2beta-diol, 3,3a-didehydro-; 476-28-8; Galanthan-1, 3,12-didehydro-9,10-[methylenebis(oxy)]-, (1.alpha.,2.beta.)-; Lycoran-1.alpha., 3,3a-didehydro-; BCBcMAP01_000100; NSC401360; HMS1791B04; Galanthan-1,2-diol, 3,12-didehydro-9,10-(methylenebis(oxy))-, (1-alpha,2-beta)-; ST085774; STOCK1N-67168; SMP1_000184; Narcissine; Galanthan-1,2-diol, 3,12-didehydro-9,10-(methylenebis(oxy))-, (1-alpha,2-beta)- (9CI); AK115153; 3,2.beta.-diol; 2,5,7,12b,12c-Hexahydro-1H-[1,3]-dioxolo[4,5-j]pyrrolo[3,2,1-de]phenanthridine-1,2-diol; AKOS000278045; (-)-lycorine; narcissine | C16H17NO4 | 287.31 g/mol | C1CN2CC3=CC4=C(C=C3C5C2C1=CC(C5O)O)OCO4 |
| TCMBANKIN059104 | prim-o-glucosylcimifugin | NP-002658; ACon1_000472; BRD-A58428623-001-01-6; MCULE-1156118860; MEGxp0_000922; MolPort-001-741-075; NCGC00169046-01;prim-o-gluco sylcimifogin | C22H28O11 | 468.4 g/mol | CC(C)(C1CC2=C(O1)C=C3C(=C2OC)C(=O)C=C(O3)COC4C(C(C(C(O4)CO)O)O)O)O |
| TCMBANKIN060293 | (?)-zuonin a | C20H20O5 | 340.4 g/mol | CC1C(C(OC1C2=CC3=C(C=C2)OCO3)C4=CC5=C(C=C4)OCO5)C |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab